Provided by Tiger Trade Technology Pte. Ltd.

Vaso Corporation

0.2230
-0.0048-2.11%
Volume:73.26K
Turnover:16.35K
Market Cap:39.24M
PE:22.33
High:0.2278
Open:0.2145
Low:0.2145
Close:0.2278
52wk High:0.2470
52wk Low:0.1050
Shares:175.95M
Float Shares:97.08M
Volume Ratio:0.55
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0100
EPS(LYR):0.0355
ROE:5.49%
ROA:1.28%
PB:1.33
PE(LYR):6.28

Loading ...

Company Profile

Company Name:
Vaso Corporation
Exchange:
OTCQX
Establishment Date:
1987
Employees:
282
Office Location:
137 Commercial Street,Unit 200,Plainview,New York,United States
Zip Code:
11803
Fax:
516 997 2299
Introduction:
Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.